Strategy for cervical cancer screening

Share This Post

Since the 1960s, due to the popularity of screening, cervical cancer deaths have declined significantly. In the United States, cervical cancer is the 18th most common cause of cancer deaths. It is expected that there will be 13,240 new cases in 2018, including 4,170 deaths. Most deaths from cervical cancer occur in people who are not adequately screened. Women in low-income communities, women of color, and women living in remote or rural areas make up these deaths related to cervical cancer.

The United States Preventive Services Task Force (USPSTF) provides new recommendations for cervical cancer screening and provides women with more testing options. The biggest change is that women between the ages of 30-65 can choose to completely abandon cervical smears. New evidence shows that human papillomavirus (HPV) is sexually transmitted and almost all cervical cancer is caused by HPV. HPV causes changes in cervical cells, which can lead to cervical cancer. Women aged 30-65 years can choose to have an HPV test every five years to screen for cervical cancer, instead of having a cervical smear every three years. Avoid unnecessary tests. Thus avoiding additional costs and more follow-up problems. This is the first time that a separate HPV test is recommended to screen for cervical cancer, and this test is recommended regardless of sexual history. But Bruder predicts that Pap smears will not be replaced soon.

In the past, the recommendation for women of this age group was a cervical smear, also known as exfoliative cytology, a cervical smear every three years or combined with an HPV test every five years (co-testing). Women can still choose to use this method to screen for cervical cancer. For women aged 21-29, it is still recommended to have a Pap smear every three years. It is not recommended for women under 21 years of age because cervical cancer under the age of 21 is rare. Similarly, women who are adequately screened for cervical cancer over the age of 65 do not need to be tested. Those who are over 65 years old and have had 3 cervical smears or 2 joint examinations have no adverse results, nor have they had any adverse results in the past 10 years, and they no longer need to undergo cervical cancer screening, even if they have a new sex partner . The new guidelines are only for women who do not have any bad test results. People who have been diagnosed with highly premalignant lesions or cervical cancer should consult their doctor to discuss their detection methods.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

CAR T Cell therapy in Mumbai, India
CAR T-Cell therapy

CAR T-Cell therapy in Mumbai, India

CAR T-cell therapy, an advanced cancer treatment, is now available in Mumbai, offering hope to those suffering from some types of blood cancers. This therapy modifies a patient’s T-cells to seek out and destroy cancer cells. It is being offered by many of the leading medical centers in Mumbai, enhancing survival rates and quality of life. With advanced technology and oncologists, Mumbai is slowly becoming a hub for CAR T-cell therapy in India.

LungVax lung cancer vaccine
Lung cancer

LungVax: Lung cancer vaccine

LungVax is an innovative lung cancer vaccine designed to stimulate the immune system to target and destroy cancer cells. It is engineered to enhance the body’s natural defense mechanisms against tumor growth, offering a novel approach to lung cancer treatment. LungVax aims to prevent recurrence in high-risk patients and improve survival rates, marking a promising development in immunotherapy for one of the deadliest forms of cancer.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) CAR T-Cell therapy
2) Gene therapy
3) Gamma-Delta T Cell therapy
4) TIL therapy
5) NK Cell therapy